Abstract

BackgroundIn view of the increasing pressure on the UK’s maternity units, new methods of labour induction are required to alleviate the burden on the National Health Service, while maintaining the quality of care for women during delivery. A model was developed to evaluate the resource use associated with misoprostol vaginal inserts (MVIs) and dinoprostone vaginal inserts (DVIs) for the induction of labour at term.MethodsThe one-year Markov model estimated clinical outcomes in a hypothetical cohort of 1397 pregnant women (parous and nulliparous) induced with either MVI or DVI at Southmead Hospital, Bristol, UK. Efficacy and safety data were based on published and unpublished results from a phase III, double-blind, multicentre, randomised controlled trial. Resource use was modelled using data from labour induction during antenatal admission to patient discharge from Southmead Hospital. The model’s sensitivity to key parameters was explored in deterministic multi-way and scenario-based analyses.ResultsOver one year, the model results indicated MVI use could lead to a reduction of 10,201 h (28.9 %) in the time to vaginal delivery, and an increase of 121 % and 52 % in the proportion of women achieving vaginal delivery at 12 and 24 h, respectively, compared with DVI use. Inducing women with the MVI could lead to a 25.2 % reduction in the number of midwife shifts spent managing labour induction and 451 fewer hospital bed days. These resource utilisation reductions may equate to a potential 27.4 % increase in birthing capacity at Southmead Hospital, when using the MVI instead of the DVI.ConclusionsResource use, in addition to clinical considerations, should be considered when making decisions about labour induction methods. Our model analysis suggests the MVI is an effective method for labour induction, and could lead to a considerable reduction in resource use compared with the DVI, thereby alleviating the increasing burden of labour induction in UK hospitals.

Highlights

  • In view of the increasing pressure on the UK’s maternity units, new methods of labour induction are required to alleviate the burden on the National Health Service, while maintaining the quality of care for women during delivery

  • Using efficacy and safety data reported in the EXPEDITE study, the objective of this study was to develop a modelbased analysis to estimate and compare healthcare resource use associated with labour induction using the misoprostol vaginal inserts (MVIs) instead of the dinoprostone vaginal inserts (DVIs) from a UK National Health Service (NHS) hospital perspective

  • A model was developed in Microsoft® Excel® to estimate the time and resource use associated with labour induction using the MVI compared with the DVI

Read more

Summary

Introduction

In view of the increasing pressure on the UK’s maternity units, new methods of labour induction are required to alleviate the burden on the National Health Service, while maintaining the quality of care for women during delivery. Maternity services in the UK National Health Service (NHS) face considerable pressure to manage births–the birth rate in England is currently at its highest since 1971 [1, 2], and is increasing [3]. This coincides with UK NHS resources being cut; spending on maternity services decreased in half the geographical regions in England from 2012 to 2013 [2]. Three quarters of inductions with the DVI require augmentation with oxytocin [11]; on average, oxytocin administration entails 14 h [12] of continuous monitoring by a healthcare professional [8]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call